BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24174529)

  • 21. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
    Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
    Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility.
    Li C; McManus FP; Plutoni C; Pascariu CM; Nelson T; Alberici Delsin LE; Emery G; Thibault P
    Nat Commun; 2020 Feb; 11(1):834. PubMed ID: 32047143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.
    Knipscheer P; van Dijk WJ; Olsen JV; Mann M; Sixma TK
    EMBO J; 2007 Jun; 26(11):2797-807. PubMed ID: 17491593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription.
    Tiefenbach J; Novac N; Ducasse M; Eck M; Melchior F; Heinzel T
    Mol Biol Cell; 2006 Apr; 17(4):1643-51. PubMed ID: 16421255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
    Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
    J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
    Li Z; Wu S; Wang J; Li W; Lin Y; Ji C; Xue J; Chen J
    Int J Mol Med; 2012 Nov; 30(5):1053-60. PubMed ID: 22895527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
    Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
    J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z; Hecker CM; Scheschonka A; Betz H
    FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BS69 undergoes SUMO modification and plays an inhibitory role in muscle and neuronal differentiation.
    Yu B; Shao Y; Zhang C; Chen Y; Zhong Q; Zhang J; Yang H; Zhang W; Wan J
    Exp Cell Res; 2009 Dec; 315(20):3543-53. PubMed ID: 19766626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins.
    Kobayashi S; Shibata H; Yokota K; Suda N; Murai A; Kurihara I; Saito I; Saruta T
    Endocr Res; 2004 Nov; 30(4):617-21. PubMed ID: 15666801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
    Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
    PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of the SUMO-related enzymes, PIAS1, PIAS4, and RNF4, in DNA double-strand break repair by homologous recombination.
    Han MM; Hirakawa M; Yamauchi M; Matsuda N
    Biochem Biophys Res Commun; 2022 Feb; 591():95-101. PubMed ID: 35007836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory.
    Chen YC; Hsu WL; Ma YL; Tai DJ; Lee EH
    J Neurosci; 2014 Jul; 34(29):9574-89. PubMed ID: 25031400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
    Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
    Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
    Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
    Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.